View PDF Version - RePub - Erasmus Universiteit Rotterdam
View PDF Version - RePub - Erasmus Universiteit Rotterdam
View PDF Version - RePub - Erasmus Universiteit Rotterdam
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Bibliography 263<br />
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment<br />
response during Peg-interferon {alpha}-2b therapy. Gut. 2005 Nov;54(11):1604-9. Epub<br />
2005 May 29.<br />
66. van Zonneveld M, Flink HJ, Verhey E, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C,<br />
So TM, Gerken G, de Man RA, Hansen BE, Schalm SW, Janssen HL; HBV 99-01 Study Group.<br />
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive<br />
factors for dose reduction and treatment discontinuation. Aliment Pharmacol Ther. 2005<br />
May 1;21(9):1163-71.<br />
67. Zonneveld, M. van, Honkoop, P., Hansen, B.E., Niesters, H.G.M., Darwish Murad, S., Man,<br />
R.A. de, Schalm, S.W. en Janssen, H.L.A.<br />
Gunstig langetermijneffect bij responders op interferonbehandeling onder patiënten met<br />
chronische hepatitis B in vergelijking tot non-responders; retrospectief onderzoek OOR-<br />
SPRONKELIJKE STUKKEN 2005; 149(27); 1510-5<br />
68. Brakel, K., Overhagen, H. van, Heijenbrok, M.W., Kasteren, J.H.L.M. van, Moosdijk, C.N.F. van<br />
de, Roldaan, A.C. en Hansen, B.E.<br />
Opsporing en diagnostiek van supraclaviculaire lymfekliermetastasen bij patiënten met aanwijzingen<br />
voor longkanker door palpatie, echografi e en CT. OORSPRONKELIJKE STUKKEN<br />
2005; 149(4); 189-95<br />
69. Ter Borg MJ, van Zonneveld M, Zeuzem S, Senturk H, Akarca US, Simon C, Hansen BE, Haagmans<br />
BL, de Man RA, Schalm SW, Janssen HL.<br />
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic<br />
hepatitis B: Relation to treatment response. Hepatology. 2006 Sep;44(3):721-7.<br />
70. Veldt BJ, Hansen BE, Ikeda K, Verhey E, Suzuki H, Schalm SW.<br />
Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with<br />
non-response or relapse to interferon. Scand J Gastroenterol. 2006 Sep;41(9):1087-94.<br />
71. Orlent H, Hansen BE, Willems M, Brouwer JT, Huber R, Kullak-Ublick GA, Gerken G, Zeuzem<br />
S, Nevens F, Tielemans WC, Zondervan PE, Lagging M, Westin J, Schalm SW.<br />
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis<br />
C: A randomized phase II trial. J Hepatol. 2006 Oct;45(4):539-46. Epub 2006 Jun 30.<br />
72. Ter Borg PC, Schalm SW, Hansen BE, van Buuren HR; for the Dutch PBC study group.<br />
Prognosis of Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cirrhosis. Results of<br />
a 10-Yr Cohort Study Involving 297 Patients. Am J Gastroenterol. 2006 Sep; 101(9):2044-50.<br />
73. Leeuwenburgh I, Van Dekken H, Scholten P, Hansen BE, Haringsma J, Siersema PD, Kuipers<br />
EJ.<br />
Oesophagitis is common in patients with achalasia after pneumatic dilatation. Aliment Pharmacol<br />
Ther. 2006 Apr 15;23(8):1197-203.<br />
74. Flink HJ, van Zonneveld M, Hansen BE, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study<br />
Group.<br />
Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss<br />
is associated with HBV genotype. Am J Gastroenterol. 2006 Feb;101(2):297-303.<br />
75. van der Eijk AA, Niesters HG, Hansen BE, Heijtink RA, Janssen HL, Schalm SW, de Man RA.